Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinic Network Collaboration and Patient Tracing to Maximize Retention in HIV Care.
McMahon JH, Moore R, Eu B, Tee BK, Chen M, El-Hayek C, Street A, Woolley I, Buggie A, Collins D, Medland N, Hoy J; Victorian Initiative for Patient Engagement and Retention VIPER Study Group. McMahon JH, et al. Among authors: eu b. PLoS One. 2015 May 26;10(5):e0127726. doi: 10.1371/journal.pone.0127726. eCollection 2015. PLoS One. 2015. PMID: 26011034 Free PMC article.
Improvements in Patient-Reported Outcomes After 12 Months of Maintenance Therapy With Cabotegravir + Rilpivirine Long-Acting Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide in the Phase 3b SOLAR Study.
Mussini C, Cazanave C, Adachi E, Eu B, Alonso MM, Crofoot G, Chounta V, Kolobova I, Sutton K, Sutherland-Phillips D, Urbaityte R, Ehmann A, Scherzer J, de Los Rios P, D'Amico R, Spreen W, van Wyk J. Mussini C, et al. Among authors: eu b. AIDS Behav. 2024 Oct 8. doi: 10.1007/s10461-024-04490-0. Online ahead of print. AIDS Behav. 2024. PMID: 39375290
Weight and metabolic changes with long-acting cabotegravir and rilpivirine or bictegravir/emtricitabine/tenofovir alafenamide.
Tan DHS, Antinori A, Eu B, Galindo Puerto MJ, Kinder C, Sweet D, Dam CNV, Sutton K, Sutherland-Phillips D, Berni A, Zhang F, Urbaityte R, Baugh B, Spreen W, Wyk JV, Garges HP, Patel P, Batterham R, D'amico R. Tan DHS, et al. Among authors: eu b. J Acquir Immune Defic Syndr. 2024 Dec 16. doi: 10.1097/QAI.0000000000003584. Online ahead of print. J Acquir Immune Defic Syndr. 2024. PMID: 39676239
Service delivery challenges in HIV care during the first year of the COVID-19 pandemic: results from a site assessment survey across the global IeDEA consortium.
Brazier E, Ajeh R, Maruri F, Musick B, Freeman A, Wester CW, Lee MP, Shamu T, Crabtree Ramírez B, d'Almeida M, Wools-Kaloustian K, Kumarasamy N, Althoff KN, Twizere C, Grinsztejn B, Tanser F, Messou E, Byakwaga H, Duda SN, Nash D; International epidemiology Databases to Evaluate AIDS. Brazier E, et al. J Int AIDS Soc. 2022 Dec;25(12):e26036. doi: 10.1002/jia2.26036. J Int AIDS Soc. 2022. PMID: 36504431 Free PMC article.
Successful expanded clinic network collaboration and patient tracing for retention in HIV care.
Bhatt S, Bryant M, Lau H, Tee BK, Eu B, O'Bryan J, Woolley I, Mitchell J, Street A, Dobinson S, Medland N, Lamb J, Mahony A, Tramontana A, Lim LL, Wade A, Roder C, Mitchell W, Sherman C, Bramwell F, Aboltins C, Wong SH, Giourouki M, Hoy JF, McMahon JH. Bhatt S, et al. Among authors: eu b. AIDS Res Ther. 2022 Dec 5;19(1):61. doi: 10.1186/s12981-022-00476-x. AIDS Res Ther. 2022. PMID: 36471425 Free PMC article.
82 results